Literature DB >> 11587163

Hypertension treatment patterns in American Indians: the strong heart study.

J A Hayslett1, J E Eichner, J L Yeh, W Wang, J Henderson, R B Devereux, T K Welty, R R Fabsitz, B V Howard, E T Lee.   

Abstract

Pharmacologic treatment patterns for hypertensive American Indians from 13 communities in Arizona, Oklahoma, South Dakota, and North Dakota were assessed. Participants (2254 women and 1384 men, aged 48 to 79 years) completed a clinical examination between July 1993 and December 1995. The mean of two blood pressure (BP) measurements and detailed medication histories were obtained. The observed prevalence of hypertension was 46.7% (n=1698). In participants taking antihypertensive medications (n=1114), four principal drug classes were evaluated: diuretics, calcium channel blocking agents, beta-blocking agents, and angiotensin-converting enzyme (ACE) inhibitors. Among treated hypertensive participants, 71.4%, 24.6%, and 4.0% received one, two, and three medications, respectively. Among single drug regimens, ACE inhibitors (n=340) were used most often (49.4%), with calcium channel blocking agents and diuretics accounting for 24.2% and 19.9%, respectively. Although multiple drug class therapies varied, the combination of a diuretic and ACE inhibitor (n=120) accounted for 47.4% of dual therapy use. Hypertension control (SBP < 140 mm Hg, DBP < 90 mm Hg) rates were highest for those on dual therapies (65.4%), followed by participants on single (53.8%) and triple (43.6%) therapies. Among monotherapies, diuretics exhibited the best overall hypertension control rate in both diabetics (63.0%) and nondiabetics (68.0%), versus 47% to 61% for other remaining agents. The frequent use of ACE inhibitors, used singly or in combination, reflects the high prevalence of diabetes among American Indians. ACE inhibitors, combined with diuretics, were particularly useful in achieving BP control in this population.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11587163     DOI: 10.1016/s0895-7061(01)02146-x

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  6 in total

1.  Cancers of the urinary tract among American Indians and Alaska Natives in the United States, 1999-2004.

Authors:  Robin Taylor Wilson; Lisa C Richardson; Janet J Kelly; Judith Kaur; Melissa A Jim; Anne P Lanier
Journal:  Cancer       Date:  2008-09-01       Impact factor: 6.860

2.  The relationship of cardiovascular risk factors to Alzheimer disease in Choctaw Indians.

Authors:  Myron F Weiner; Linda S Hynan; Heidi Rossetti; Kyle B Womack; Roger N Rosenberg; Yun-Hua Gong; Bao-Xi Qu
Journal:  Am J Geriatr Psychiatry       Date:  2011-05       Impact factor: 4.105

Review 3.  Metabolic Syndrome Among American Indian and Alaska Native Populations: Implications for Cardiovascular Health.

Authors:  Timian M Godfrey; Felina M Cordova-Marks; Desiree Jones; Forest Melton; Khadijah Breathett
Journal:  Curr Hypertens Rep       Date:  2022-02-18       Impact factor: 4.592

4.  A longitudinal study of risk factors for incident albuminuria in diabetic American Indians: the Strong Heart Study.

Authors:  Jiaqiong Xu; Elisa T Lee; Richard B Devereux; Jason G Umans; Jonathan N Bella; Nawar M Shara; Jeunliang Yeh; Richard R Fabsitz; Barbara V Howard
Journal:  Am J Kidney Dis       Date:  2008-03       Impact factor: 8.860

Review 5.  Systems for care of hypertension in the United States.

Authors:  Lawrence R Krakoff
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-06       Impact factor: 3.738

6.  Cadmium body burden and increased blood pressure in middle-aged American Indians: the Strong Heart Study.

Authors:  N Franceschini; R C Fry; P Balakrishnan; A Navas-Acien; C Oliver-Williams; A G Howard; S A Cole; K Haack; E M Lange; B V Howard; L G Best; K A Francesconi; W Goessler; J G Umans; M Tellez-Plaza
Journal:  J Hum Hypertens       Date:  2016-09-15       Impact factor: 3.012

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.